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1. INTRODUCTION {#fsn31648-sec-0001}
===============

Toxoplasmosis caused by an intracellular parasite, *Toxoplasma gondii*, is frequently reported from almost all countries (Montoya & Liesenfeld, [2004](#fsn31648-bib-0022){ref-type="ref"}; Robert‐Gangneux & Darde, [2012](#fsn31648-bib-0026){ref-type="ref"}). The infection may occur via vertical transmission from infected mothers, white blood cell (WBC) transfusion, transplantation, consumption of contaminated food and water, and close contact to infected cats (Hide, [2016](#fsn31648-bib-0012){ref-type="ref"}; Hill & Dubey, [2002](#fsn31648-bib-0013){ref-type="ref"}, [2016](#fsn31648-bib-0014){ref-type="ref"}).

Tachyzoite, bradyzoite, and oocyst are the main three forms of *Toxoplasma\'s* life cycle. Tachyzoites are responsible for the acute phase of toxoplasmosis while bradyzoites are seen in tissue cysts and chronic phase of infection (Montoya & Liesenfeld, [2004](#fsn31648-bib-0022){ref-type="ref"}). Toxoplasmosis is known as an asymptomatic infection in the chronic phase. Nonetheless, acute toxoplasmosis could be a life‐threatening infection which is mostly reported from immunocompromised patients, particularly HIV/AIDS patients with TCD~4~ counts less than 100/mm^3^ peripheral blood (Ahmadpour et al., [2019](#fsn31648-bib-0001){ref-type="ref"}; Faucher, Moreau, Zaegel, Franck, & Piarroux, [2011](#fsn31648-bib-0011){ref-type="ref"}; Safarpour et al., [2020](#fsn31648-bib-0027){ref-type="ref"}). Currently, a panel of antibiotics is being recommended and widely practiced for both chronic and acute toxoplasmosis (Alday & Doggett, [2017](#fsn31648-bib-0003){ref-type="ref"}). Accordingly, a combination of sulfadiazine and pyrimethamine is known as a standard antibiotic therapy for toxoplasmosis (Alday & Doggett, [2017](#fsn31648-bib-0003){ref-type="ref"}; Montazeri et al., [2017](#fsn31648-bib-0021){ref-type="ref"}). Moreover, clindamycin, pentamidine, atovaquone, and azithromycin are another drugs of choice which are widely prescribed in the clinical practices (Alday & Doggett, [2017](#fsn31648-bib-0003){ref-type="ref"}). However, low bioavailability, need for a high dosage, and wide side effects including bone marrow suppression, diarrhea, and abdominal pain limit prescription of these drugs (Alday & Doggett, [2017](#fsn31648-bib-0003){ref-type="ref"}; Darade, Pathak, Sharma, & Patravale, [2018](#fsn31648-bib-0008){ref-type="ref"}).

During the recent decades, herbal medicine has been explained and practiced as an alternative therapy with low toxicity for a broad range of infective and noninfective diseases (Choi, Gang, & Yun, [2008](#fsn31648-bib-0007){ref-type="ref"}; Kheirandish et al., [2016](#fsn31648-bib-0015){ref-type="ref"}; Seo et al., [2019](#fsn31648-bib-0028){ref-type="ref"}; Yadav & Temjenmongla, [2012](#fsn31648-bib-0032){ref-type="ref"}; Yeom et al., [2015](#fsn31648-bib-0033){ref-type="ref"}). *Mentha* belongs to Labaiatae family (Bhat, Maheshwari, Kumar, & Kumar, [2002](#fsn31648-bib-0004){ref-type="ref"}) and is found all over the world. *Mentha pulegium* L. is a species of this genus that its antimicrobial effects have been evaluated on bacteria and protozoa (Bouyahya et al., [2017](#fsn31648-bib-0006){ref-type="ref"}; Mahboubi & Haghi, [2008](#fsn31648-bib-0019){ref-type="ref"}). *Rubus idaeus* L. belongs to *Rubus* genus and Rosaceae family, mainly grows in the north regions of Iran (Moreno‐Medina, Casierra‐Posada, & Cutler, [2018](#fsn31648-bib-0023){ref-type="ref"}; Nalbandi, Seiiedlou, Hajilou, & Adlipour, [2011](#fsn31648-bib-0024){ref-type="ref"}). Although many studies investigated the anticancer, anti‐inflammation, and antimicrobial effects of the genus *Rubus* (Krauze‐Baranowska, Glod, et al., [2014](#fsn31648-bib-0017){ref-type="ref"}; Krauze‐Baranowska, Majdan, et al., [2014](#fsn31648-bib-0018){ref-type="ref"}; Seo et al., [2019](#fsn31648-bib-0028){ref-type="ref"}), there is no available data suggesting anti‐parasitic effects of this plant.

In the current study, chemical compositions of crude aquatic extracts of *M. pulegium* L. and *R. idaeus* L. and their anti‐*Toxoplasma* were evaluated.

2. MATERIAL AND METHODS {#fsn31648-sec-0002}
=======================

2.1. Extract preparation {#fsn31648-sec-0003}
------------------------

*R. idaeus* L. and *M. pulegium* L. aerial parts were hand‐picked on same day from a local farm in the northern parts of Iran in August 2016. Plants were air‐dried in 25°C, away from sunshine, with continuous air ventilation until a constant weight obtained. Extraction was performed on powdered dry plant using decoction technique. Briefly, 500 g of plants were subjected to 2 L of distilled water and boiled until the volume decreased to its 1/4. Then, the mixtures were filtered and the extracts were concentrated using indirect heat.

2.2. Extract analyses {#fsn31648-sec-0004}
---------------------

### 2.2.1. Gas chromatography (GC)/mass spectrometry (MS) {#fsn31648-sec-0005}

Crude aquatic extracts of *R. idaeus* L. and *M. pulegium* L. were subjected to a solvent--solvent partitioning with petroleum ether, chloroform, and ethanol. Main components existing in resulted fractions were identified by GC‐MS using a HP‐5ms column (30 m × 0.25 mm, film thickness 0.25 μm; Agilent Technology). Temperature of the column was maintained at 50˚C for 1 min and programmed to 250˚C at a rate of 3˚C per min, and was constant at 250˚C for 20 min. Injector and detector temperatures were 250˚C and 230˚C, respectively. The flow rate of the carrier gas was 1 ml/min. Helium 99.999% was used as the carrier gas with ionization voltage of 70 eV. Mass range was from 40 to 400 u. Identification of the components was performed by comparison of their relative retention time and mass spectra to the standards (Wiley 7 library data of the GC‐MS system).

### 2.2.2. HPTLC analysis {#fsn31648-sec-0006}

#### Instruments {#fsn31648-sec-0007}

Silica gel 60 F254 glass plates (10 × 20 cm with 200 µm thickness HPTLC; Merck), CAMAG automatic thin layer chromatographic (TLC), Sampler 4 (ATS 4), CAMAG automatic developing chamber 2 (ADC 2), CAMAG TLC Visualizer, and winCATS version 1.4.4 software (CAMAG) were used in this study.

#### Solvent extraction {#fsn31648-sec-0008}

In order to cover a wide range of polarity, 0.1 g of *R. idaeus* L. total extract was subjected to a serial extraction with four organic solvents, starting from an absolutely nonpolar solvent (hexane) followed by gradually increasing polarity solvents (ethyl acetate, chloroform, methanol). Next, acid and alkaline extraction were performed on methanol components by using HCl 0.1 M and NH~3~ 10% v/v. The final extraction of salts was accomplished with chloroform.

#### Chromatographic experiment and phytochemical screening {#fsn31648-sec-0009}

HPTLC is illustrative for expansion of chromatographic fingerprints to determine major active constituents of medicinal plants. It also presented a more efficient separation of individual secondary metabolites. 10 µl of each sample solutions were applied on the TLC plate using ATS 4 in the form of band (band width: 6 mm, distance between two bands: 9.4 mm). A constant application rate of 150 nl/s was used with the mobile phase of chloroform--methanol (8:2) v/v. The plates were then placed in the mobile phase, and ascending development was performed to a distance of 7 cm. Subsequent to the development, the plates were air‐dried and chromatograms were evaluated with TLC visualizer under 254 nm and under 366nm, and white light.

Qualitative TLC analysis was performed. Accordingly, chloroform--methanol (7:3) was the mobile phase system and silica gel 60 F 254 HPTLC plate was incorporated as stationary phase. Five different reagents including anisaldehyde sulfuric acid, dragendorff, ninhydrin, potassium hydroxide, and sulfuric acid were utilized to describe the secondary metabolic compounds (terpenoids, saponins, alkaloids, amino acids, antraquinones), which were found in extracts. The plate was documented in daylight and at UV 366 nm mode using the photo‐documentation chamber.

2.3. *T. Gondii* strain {#fsn31648-sec-0010}
-----------------------

At the first step, the RH strain of *T. gondii* was kindly supplied by Dr. SJ Seyed Tabaei from intraperitoneal (IP) passages of *Toxoplasma* in female BALB/c mice (8‐ to 10‐week‐old, 20--25 g weight), 3--4 day after IP injection with 1 × 10^7^ of the parasite. All mice were housed in cages under standard laboratory conditions including an average temperature (20--25°C), humidity (60 ± 10%), light (12 hr per day), given drinking water, and regular diet in the animal center of Shahid Beheshti University of Medical Sciences of Tehran, Iran.

The tachyzoites were collected from peritoneal cavity of infected mice. Afterward, the parasites were washed using sterile PBS (pH: 7.4), counted by hemocytometer slide, and 1.5 × 10^6^ tachyzoites were inoculated to the Vero cells, kidney fibroblast from the African green monkey, cultivated in dulbecco\'s modified eagle\'s medium (DMEM) supplemented with 10% heat‐inactivated fetal bovine serum (FBS) and 1% penicillin/streptomycin for mass‐cultivation.

2.4. Cell culture {#fsn31648-sec-0011}
-----------------

Vero cells were used for in vitro assays. In this regard, the cells were cultivated in DMEM medium, supplemented with 10% heat‐inactivated FBS and 1% penicillin and streptomycin. Cultured media were maintained at 37°C in 5% CO~2~. When the cells reach to 80% confluent, sub‐culture was performed.

2.5. Cell toxicity assay for *Vero* cell {#fsn31648-sec-0012}
----------------------------------------

To evaluate the cell toxicity of the herbs, Vero cells were seeded in 96‐well plates (cell suspensions 2.4 × 10^5^ cell/mL in complete culture medium DMEM and incubated at 37°C in 5% CO~2~ for 48 hr). After 48 hr, serial dilutions 10^−1^ to 10^−6^ of each *R. idaeus* L. and *M. pulegium* L. extract were added and incubated at 37°C in 5% CO~2~ for 2 days. After 48 hr, the cell viability was measured by adding MTT solution (3‐(4,5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide) to the cultures. A well of Vero cell without treatment was considered as negative control. After 4 hr, the experiment was stopped by DMSO and the results were read at wavelength 590 using an enzyme‐linked immunosorbent assay (ELISA) microplate reader (LX800; Biotec, Winooski, VA, USA). All experiments were performed in duplicate. The nonviable Vero cells were calculated using the following equation (Khosravi et al., [2020](#fsn31648-bib-0016){ref-type="ref"}), and the 50% cytotoxic concentrations (CC50s) were calculated using the Graph Pad Prism 6.0 software (Graph Pad Software, Inc., San Diego, USA).$${\text{Viable\ microorganisms}\mspace{6mu}}\% = \left\lbrack {\left( {\text{AT} - \text{AB}} \right)/\left( {\text{AC} - \text{AB}} \right)} \right\rbrack \times 100,$$ $${\text{Nonviable\ microorganisms}\mspace{6mu}}\% = 100 - {\text{Viable\ microorganisms}\mspace{6mu}}\%.$$

AT is the OD of treated well, AC is the OD of negative control, and AB is the OD of the blank well.

2.6. Effect of the plant extracts on tachyzoites of *Toxoplasma* {#fsn31648-sec-0013}
----------------------------------------------------------------

To evaluate the toxicity of the extracts, 1 × 10^6^ tachyzoites per well of *T. gondii* were added to a 96‐well plate containing DMEM supplemented with 10% FBS without antibiotics; then, serial dilutions 10^−1^ to 10^−6^ of the extracts were added to wells. After 2 hr, 10 µl of *T. gondii* from each well containing different concentrations of the extracts was stained by trypan blue, and the number of alive cells was calculated using hemocytometer slide and optical microscopy. A well containing *T. gondii* without any herbal extract was considered as negative control. All tests performed in duplicate. $$1 - \frac{\text{Test}}{\text{Control}} \times 100.$$

The above equation represents the percentage of the dead tachyzoites. Test: the mean number of alive tachyzoites in each concentration; control: the mean number of alive tachyzoites in control wells.

The lethal concentration (LC) was calculated and the mean 50% (LC50) was estimated from the dose--response curves of *M. pulegium* L. and *R. idaeus* L. different concentrations by using the Graph Pad Prism 6.0 software.

2.7. Statistical analysis {#fsn31648-sec-0014}
-------------------------

Statistical analyses were performed on all data using Graph Pad Prism (version 6.07) software. Differences between test and control groups were analyzed by one‐sample *t* test. *p* \< .05 was considered as statistically significant.

3. RESULTS {#fsn31648-sec-0015}
==========

3.1. GC‐MS analysis {#fsn31648-sec-0016}
-------------------

In all three fractions of *M. pulegium* L., menthol and limonene were identified as two components (Table [1](#fsn31648-tbl-0001){ref-type="table"}). As a result, menthol was the main component of *M. pulegium* L. (99.23%). Moreover, *R. idaeus* L. was constituted by at least fifteen components with approximately equal percentage while 3‐Decen‐5‐one, 2‐methyl‐ (CAS) and m‐Cymene showed the higher (1.198%) and lower (0.017%) percentages (Table [2](#fsn31648-tbl-0002){ref-type="table"}).

###### 

Main components of *M. pulegium* L. identified by GC‐MS

  Peak \#   RT[\*](#fsn31648-note-0002){ref-type="fn"}   Compound   Area        \%
  --------- -------------------------------------------- ---------- ----------- --------
  1         4.2                                          Limonene   292.00623   0.227
  2         7.4                                          Menthol    1.27583e5   99.233

Retention time.

John Wiley & Sons, Ltd

###### 

Main components of *R. idaeus* L. identified by GC‐MS

  Peak \#   RT       Compound                                                                    Area         \%
  --------- -------- --------------------------------------------------------------------------- ------------ -------
  1         10.76    m‐Cymene                                                                    163,664      0.017
  2         12.774   Hexachloroethane                                                            3,706,218    0.388
  3         17.193   1,2‐Dipentylcyclopropene                                                    1,638,278    0.172
  4         20.551   Carvone                                                                     4,359,664    0.457
  5         22.055   1‐Oxaspiro\[4.5\]dec−7‐ene, 2,10,10‐trimethyl−6‐methylene‐, trans‐(.+‐.)‐   819,644      0.086
  6         22.381   Anethole                                                                    320,748      0.034
  7         27.201   Tetradecane                                                                 2,286,912    0.240
  8         31.263   Pentadecane                                                                 4,110,038    0.430
  9         35.121   Hexadecane                                                                  3,327,976    0.349
  10        47.925   3‐Decen−5‐one, 2‐methyl‐ (CAS)                                              11,441,980   1.198
  11        49.471   Sulfur                                                                      2,341,202    0.245
  12        53.763   7,9‐Dihydroxy−5‐methoxy−2‐methyl−1,4‐anthracenedione                        503,916      0.053
  13        63.808   6 METHYL−2 PHENYLINDOLE                                                     1,018,981    0.107
  14        64.621   1‐Methyl−2‐phenylindole                                                     899,925      0.094
  15        65.27    2‐Methyl−3‐phenylindole                                                     556,425      0.058

John Wiley & Sons, Ltd

3.2. Phytochemistry and HPTLC analyses {#fsn31648-sec-0017}
--------------------------------------

HPTLC presented the fingerprint of *R. idaeus* extract\'s constituents. Constituents were individualized due to a serial extraction of total extract with hexane, ethyl acetate, chloroform, methanol, HCl, and NH~3~ as specified spots on TLC paper, under white light, and UV light (366 and 254 nm) (Figure [1](#fsn31648-fig-0001){ref-type="fig"}). Preliminary phytochemical analysis obtained from exposure of *R. idaeus* fingerprint to secondary metabolite reagents (anisaldehyde sulfuric acid, dragendorff\`s, ninhydrin, potassium hydroxide, and sulfuric acid) revealed the presence of terpenoids, esterols, and flavonoids based on color zones obtained (Figure [2](#fsn31648-fig-0002){ref-type="fig"}).

![HPTLC analysis of *R. idaeus* L. Total extract was again extracted with: 1‐hexane 2‐ethyl acetate 3‐chloroform 4‐methanol 5‐HCL 6‐NH3. under (a) brown white light (b) green 366 nm and (c) blue 254 nm](FSN3-8-3656-g001){#fsn31648-fig-0001}

![Phytochemical analysis of *R. idaeus* L. extract under (a) visible and (b) UV light with secondary metabolite reagents: 1‐ anisaldehyde sulfuric acid, 2‐ dragendorff\`s, 3‐ natural products, 4‐ ninhydrin, 5‐ potassium hydroxide, and 6‐ sulfuric acid](FSN3-8-3656-g002){#fsn31648-fig-0002}

3.3. Cell viability of Vero in different concentrations of *M. pulegium* L. and *R. idaeus L*. extracts {#fsn31648-sec-0018}
-------------------------------------------------------------------------------------------------------

To analyze the toxicity of extracts on host cells, we investigated cell viability of Vero cell treated with *M. pulegium* L. and *R. idaeus* L. at the concentrations ranging from 10^−1^ to 10^−6^ using the MTT assay.

### 3.3.1. *R. idaeus* L {#fsn31648-sec-0019}

MTT results showed that *R. idaeus* L. extract significantly reduced cell viability of Vero cells in concentrations more than 10^−5^. Accordingly, the results showed that the CC50 of *R. idaeus* L. was about 10^−4^ (CC50 ≥ 10^−4^). The results showed that in the highest concentrations (10^−1^) of the extract, 40% of Vero cells survived while at the lowest concentration (10^−6^), 60% of Vero cells survived (Figure [3a](#fsn31648-fig-0003){ref-type="fig"}; Table [3](#fsn31648-tbl-0003){ref-type="table"}).

![Ratio analyses of (a) *R. idaeus* L. and (b) *M. pulegium* L. show anti‐*Toxoplasma* and cell toxicity of the extracts. CC50 and LC50 for *R. idaeus* L. are at the concentrations more than 10^−4^ and 10^−5^, respectively, while CC50 for *M. pulegium* L. is more than 10^−2^, and LC50 is ≥ 10^−6^](FSN3-8-3656-g003){#fsn31648-fig-0003}

###### 

Viability of Vero cell to different concentrations of *M. pulegium* L. and*R. idaeus* L

+----------------+------------------+------------------+----------------+------------------+------------------------------------------+
| Concentrations | *M. pulegium* L. | *R. idaeus* L.   | ***P‐*value**  |                  |                                          |
|                |                  |                  |                |                  |                                          |
| Log^10^        |                  |                  | **\<0.0001**   |                  |                                          |
+================+==================+==================+================+==================+==========================================+
| 10^−1^         | 45.2 ± 0.255     | 42.913 to 47.487 | 39.66 ± 0.509  | 35.086 to 44.234 | [\*](#fsn31648-note-0003){ref-type="fn"} |
+----------------+------------------+------------------+----------------+------------------+------------------------------------------+
| 10^−2^         | 58.18 ± 0.071    | 57.545 to 58.815 | 43.595 ± 0.403 | 39.974 to 47.216 |                                          |
+----------------+------------------+------------------+----------------+------------------+------------------------------------------+
| 10^−3^         | 61 ± 0.636       | 55.282 to 66.713 | 45.735 ± 0.417 | 41.978 to 49.483 |                                          |
+----------------+------------------+------------------+----------------+------------------+------------------------------------------+
| 10^−4^         | 68.655 ± 0.544   | 63.763 to 73.547 | 50.225 ± 0.177 | 48.637 to 51.813 |                                          |
+----------------+------------------+------------------+----------------+------------------+------------------------------------------+
| 10^−5^         | 88.115 ± 0.629   | 82.461 to 93.769 | 59.905 ± 0.148 | 58.571 to 61.239 |                                          |
+----------------+------------------+------------------+----------------+------------------+------------------------------------------+
| 10^−6^         | 98 ± 0.156       | 96.602 to 99.398 | 63.865 ± 0.516 | 59.227 to 68.503 |                                          |
+----------------+------------------+------------------+----------------+------------------+------------------------------------------+

statistically significant.

John Wiley & Sons, Ltd

### 3.3.2. *M. pulegium* L {#fsn31648-sec-0020}

MTT results of treatment with *M. pulegium* L. showed CC50 higher than 10^−2^ (CC50 \> 10^−2^). In addition, apart from the highest concentration (10^−1^), in all other concentrations (lower then 10^−2^), more than 60% of Vero cells were observed alive. Also the results showed that at the lowest concentration (10^−6^), almost 100% of the cells survived (Figure [3b](#fsn31648-fig-0003){ref-type="fig"}; Table [3](#fsn31648-tbl-0003){ref-type="table"}).

3.4. Effects of *M. pulegium* L. and *R. idaeus* L.extracts on *T. gondii* {#fsn31648-sec-0021}
--------------------------------------------------------------------------

To analyze the anti‐*Toxoplasma* effects of each extract, different concentrations of *M. pulegium* L. and *R. idaeus* L. extracts were examined.

### 3.4.1. *R. idaeus* L {#fsn31648-sec-0022}

The *R. idaeus* L. extract showed anti‐*Toxoplasma* activity at all concentrations. However, all concentrations more than 10^−5^ were able to kill more than 50% of the parasites. In addition, in the highest concentrations (10^−1^), *R. idaeus* L. extract was toxic for more than 90% of the parasites. Therefore, LC50 of *R. idaeus* L. was ≥ 10^−5^ (LC50 ≥ 10^−5^) (*P‐*value \< 0.05) (Figure [3a](#fsn31648-fig-0003){ref-type="fig"}; Table [4](#fsn31648-tbl-0004){ref-type="table"}).

###### 

Anti‐*Toxoplasma* activity of different concentrations of *M. pulegium* L., and *R. idaeus* L., and ratio values (anti‐parasite activity per Vero cell viability)

+----------------+------------------+------------------+----------------------------------------------+----------------+------------------+----------------------------------------------+--------------------------------------------+
| Concentrations | *M. pulegium* L. | *R. idaeus* L.   | *P‐*value                                    |                |                  |                                              |                                            |
|                |                  |                  |                                              |                |                  |                                              |                                            |
| (Log 10^−1^)   |                  |                  | \<0.0001                                     |                |                  |                                              |                                            |
+================+==================+==================+==============================================+================+==================+==============================================+============================================+
| 10^−1^         | 86.65 ± 0.636    | 80.932 to 92.368 | 1.91                                         | 89.31 ± 0.410  | 85.625 to 92.995 | 2.25                                         | [\*\*](#fsn31648-note-0005){ref-type="fn"} |
+----------------+------------------+------------------+----------------------------------------------+----------------+------------------+----------------------------------------------+--------------------------------------------+
| 10^−2^         | 83.1 ± 0.424     | 79.288 to 86.912 | 1.42                                         | 80.1 ± 0.410   | 76.415 to 83.785 | 1.83                                         |                                            |
+----------------+------------------+------------------+----------------------------------------------+----------------+------------------+----------------------------------------------+--------------------------------------------+
| 10^−3^         | 83 ± 0.424       | 79.188 to 86.812 | 1.36                                         | 73.55 ± 0.636  | 67.832 to 79.268 | 1.61                                         |                                            |
+----------------+------------------+------------------+----------------------------------------------+----------------+------------------+----------------------------------------------+--------------------------------------------+
| 10^−4^         | 74.55 ± 0.354    | 71.373 to 77.727 | 1.08[\*](#fsn31648-note-0004){ref-type="fn"} | 70.755 ± 0.346 | 67.642 to 73.868 | 1.41                                         |                                            |
+----------------+------------------+------------------+----------------------------------------------+----------------+------------------+----------------------------------------------+--------------------------------------------+
| 10^−5^         | 72.91 ± 0.269    | 70.496 to 75.324 | 0.82                                         | 51.655 ± 0.502 | 47.144 to 56.166 | 0.86[\*](#fsn31648-note-0004){ref-type="fn"} |                                            |
+----------------+------------------+------------------+----------------------------------------------+----------------+------------------+----------------------------------------------+--------------------------------------------+
| 10^−6^         | 70.99 ± 0.014    | 70.863 to 71.117 | 1.38                                         | 32.33 ± 0.467  | 32.330 to 36.523 | 0.50                                         |                                            |
+----------------+------------------+------------------+----------------------------------------------+----------------+------------------+----------------------------------------------+--------------------------------------------+

The ratios closer to 1 show the best concentration of drugs with highest anti‐*Toxoplasma* activity and lowest Vero toxicity.

Statistically significant.

John Wiley & Sons, Ltd

### 3.4.2. *M. pulegium* L {#fsn31648-sec-0023}

The *M. pulegium* L. extract showed high anti‐*Toxoplasma* activity (killed more than 70% of the parasites) at all concentrations with *P‐*value \< 0.05 (LC50 ≥ 10^−6^) (Figure [3b](#fsn31648-fig-0003){ref-type="fig"}; Table [4](#fsn31648-tbl-0004){ref-type="table"}).

3.5. Ratio analysis {#fsn31648-sec-0024}
-------------------

In order to calculate the best concentration with highest anti‐*Toxoplasma* activity and lowest cell toxicity, ratio analysis was performed. The value closer to 1 considered as the recommended value. Accordingly, 10^−4^ with ratio 1.08 was the suggested concentration with highest and lowest anti‐*Toxoplasma* and cell toxicity, respectively, for *M. pulegium* L. The concentration 10^−5^ of *R. idaeus* L. with ratio 0.86 seems to be the best concentration.

4. DISCUSSION {#fsn31648-sec-0025}
=============

During recent years, interest on the traditional drugs, particularly herbal medicine, is being dramatically increased (Kheirandish et al., [2016](#fsn31648-bib-0015){ref-type="ref"}). It seems that lower side effects and costs are the main reasons of this interest. Plenty of studies have practiced different herbal extracts on both helminths (Dejani et al., [2014](#fsn31648-bib-0009){ref-type="ref"}; Yadav & Tangpu, [2008](#fsn31648-bib-0030){ref-type="ref"}, [2012](#fsn31648-bib-0031){ref-type="ref"}; Yadav & Temjenmongla, [2012](#fsn31648-bib-0032){ref-type="ref"}) and protozoa (Dyab, Yones, Ibraheim, & Hassan, [2016](#fsn31648-bib-0010){ref-type="ref"}; Kheirandish et al., [2016](#fsn31648-bib-0015){ref-type="ref"}; Mirzaalizadeh et al., [2018](#fsn31648-bib-0020){ref-type="ref"}; Ribeiro et al., [2014](#fsn31648-bib-0025){ref-type="ref"}) that the results of most of them were promising. Among parasites, although most of experiments were carried out on *Leishmania* spp. (Bouyahya et al., [2017](#fsn31648-bib-0006){ref-type="ref"}; Kheirandish et al., [2016](#fsn31648-bib-0015){ref-type="ref"}; Ribeiro et al., [2014](#fsn31648-bib-0025){ref-type="ref"}), a couple of studies evaluated the anti‐*Toxoplasma* effects of herbal extracts using in vitro and in vivo studies (Al Nasr, Ahmed, Pullishery, El‐Ashram, & Ramaiah, [2016](#fsn31648-bib-0002){ref-type="ref"}).

Acute toxoplasmosis could be a fatal infection in immunocompromised patients (Montoya & Liesenfeld, [2004](#fsn31648-bib-0022){ref-type="ref"}). Although there is a list of drugs of choice for both acute and chronic toxoplasmosis, the main limitations of the current antibiotics are low bioavailability, and side effects (Alday & Doggett, [2017](#fsn31648-bib-0003){ref-type="ref"}; Darade et al., [2018](#fsn31648-bib-0008){ref-type="ref"}). In the current study, the chemical compositions of *M. pulegium* L. and *R. idaeus* L. from the local farms in the north of Iran were determined and the cell toxicity and anti*‐Toxoplasma* activity of them were evaluated.

The chemical compositions of the essential oil of *M. pulegium* L. were previously analyzed by Mahboubi and Haghi ([2008](#fsn31648-bib-0019){ref-type="ref"}) who reported piperitone, piperitenone, α‐terpineol, and pulegone as the main components. In this line, although studies showed the presence of piperitone, piperitenone, pulegone, and isomenthone/neoisomenthol as the major oil components of the *M. pulegium* L. essential oil (Bouyahya et al., [2017](#fsn31648-bib-0006){ref-type="ref"}; Mahboubi & Haghi, [2008](#fsn31648-bib-0019){ref-type="ref"}), there are no data about the components of the aquatic extract of this plant. In the current study, menthol (99.23%) and limonene (0.227%) were the main compounds of the aquatic extract of *M. pulegium* L. It seems that differences during the extract preparation are the main reason for different extracted compounds in our study in comparison to the others.

However, the antimicrobial effects of *M. pulegium* L. and its compounds have been widely practiced. Mahboubi and Haghi ([2008](#fsn31648-bib-0019){ref-type="ref"}) showed that the *M. pulegium* L. essential oil extract had significant antimicrobial effects, particularly on the Gram‐positive bacteria. In studies conducted by Dejani et al. ([2014](#fsn31648-bib-0009){ref-type="ref"}) and Zaia et al., ([2016](#fsn31648-bib-0034){ref-type="ref"}), the anti‐*Schistosoma* (*S. mansoni*) and anti‐inflammatory effects of crude ethanol extract and menthol from *M. piperita* L., respectively, were investigated that the findings were promising. In another study by Bouyahya et al. ([2017](#fsn31648-bib-0006){ref-type="ref"})*,* pulegone and menthone were characterized as the major compounds of *M. pulegium* which showed anti‐*Leishmania* activity at the concentrations from 0.875 to 10 µl/ml. In the current study, the extract of *M. pulegium* L. showed cell toxicity at the concentration \> log 10^−2^ which suggests a low cell toxicity at the high concentration. Furthermore, all dilutions (10^−6^ to 10^−1^) showed anti‐*Toxoplasma* activity (more than 70% of the parasite) suggesting high anti‐*Toxoplasma* activity beside low cell toxicity at the high concentrations.

Iranian genotypes of *R. idaeus* L. (red raspberry) grow in the northern provinces of the country (Nalbandi et al., [2011](#fsn31648-bib-0024){ref-type="ref"}). Although chemical compositions and antimicrobial activity of the Iranian strains of this plant have not been investigated, European genotypes of *R. idaeus* L. are known as a traditional herbal medicine in the Eastern Europe (Krauze‐Baranowska, Glod, et al., [2014](#fsn31648-bib-0017){ref-type="ref"}). Velicanski, Cvetkovic, and Markov ([2012](#fsn31648-bib-0029){ref-type="ref"}) investigated the antimicrobial activity of both fruit and pomace extracts of *R. idaeus* L., and showed antimicrobial activity of the extracts on *Pseudomonas aeruginosa*, *Bacillus cereus*, *Staphylococcus aureus*, and *S. saprophyticus* while *Escherichia coli* was the most resistant bacterium. In the study conducted by Bobinaitė, Viškelis, Šarkinas, and Venskutonis ([2013](#fsn31648-bib-0005){ref-type="ref"}), the contents of fruit, pulp, and marc extractions of raspberry in methanol and acetone solvents were evaluated that despite of differences in antimicrobial activity regarding parts of raspberry and solvents, the results were promising. Moreover, Krauze‐Baranowska, Glod, et al. ([2014](#fsn31648-bib-0017){ref-type="ref"}) revealed that ellagic acid and sanguiin were the predominant compounds of the young shoots of *R. idaeus* L. In addition, they showed antioxidant, antimicrobial (strongly against *Corynebacterium diphtheria*), and cytotoxicity activities (against HeLa and HL‐60 cells, but not on the fibroblastic cells) of the plant.

In the current study for the first time, phytochemical compositions of Iranian genotypes of *R. idaeus* L. were characterized and terpenoids, esterols, and flavonoids were described. Although many studies evaluated the antimicrobial activity of this plant, there are no data on the anti‐parasitic activity of *R. idaeus* L. However, our findings showed LC50 ≥ 10^−5^ against *Toxoplasma* while CC50 ≤ 10^−4^ was observed for Vero cell. The high cell toxicity of *R. idaeus* L. in this study is in line with previous studies representing cytotoxicity of the extracts of this plant on HeLa and HL‐60 cell which are cancer cell lines.

5. CONCLUSION {#fsn31648-sec-0026}
=============

According to our findings, both *R. idaeus* L. and *M. pulegium* L. revealed anti‐*Toxoplasma* activity. In addition, cytotoxicity activity of *R. idaeus* L. was significantly higher than that in *M. pulegium* L. Therefore, although anti‐*Toxoplasma* activity of both *R. idaeus* L. and *M. pulegium* L. extracts might be promising, our results showed that *M. pulegium* L. extract could be more applicable due to its lower cell toxicity in higher concentration in comparison to *R. idaeus* L.
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